Issue 1 (2024)

Summary

Articles

Impact of Cytomegalovirus (CMV) on an Academic Pediatric Infectious Diseases Outpatient Clinic Referral Population, 2005–2020: Will the Advent of Universal Congenital CMV (cCMV) Screening Change Clinical Practice Referral Patterns?
Stakeholder Views of the Proposed Introduction of Next Generation Sequencing into the Cystic Fibrosis Screening Protocol in England
Past as Prologue: Predicting Potential Psychosocial–Ethical Burdens of Positive Newborn Screens as Conditions Propagate
Leading Risk Factors for Congenital Deafness in the Context of Universal Neonatal Screening: Our Observations in a Four-Year Retrospective Study
Newborn Screening for Krabbe Disease: Status Quo and Recommendations for Improvements
Establishment of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in Saint Petersburg
Experiences and Challenges with Congenital Hypothyroidism Newborn Screening in Indonesia: A National Cross-Sectional Survey
Australian Public Perspectives on Genomic Newborn Screening: Risks, Benefits, and Preferences for Implementation
A Case of DNAJC12-Deficient Hyperphenylalaninemia Detected on Newborn Screening: Clinical Outcomes from Early Detection
Influence of Season, Storage Temperature and Time of Sample Collection in Pancreatitis-Associated Protein-Based Algorithms for Newborn Screening for Cystic Fibrosis
Landscape Analysis of Neurodevelopmental Comorbidities in Newborn Screening Conditions: Challenges and Opportunities
Light and Shadows in Newborn Screening for Lysosomal Storage Disorders: Eight Years of Experience in Northeast Italy
Incidental Detection of Classical Galactosemia through Newborn Screening for Phenylketonuria: A 10-Year Retrospective Audit to Determine the Efficacy of This Approach
Current State and Innovations in Newborn Screening: Continuing to Do Good and Avoid Harm
Droplet Digital PCR (ddPCR) Does Not Enhance the Sensitivity of Detection of Cytomegalovirus (CMV) DNA in Newborn Dried Blood Spots Evaluated in the Context of Newborn Congenital CMV (cCMV) Screening
Newborn Screening for Severe Combined Immunodeficiency: Lessons Learned from Screening and Follow-Up of the Preterm Newborn Population
Newborn Genetic Screening—Still a Role for Sanger Sequencing in the Era of NGS
A False-Negative Newborn Screen for Tyrosinemia Type 1—Need for Re-Evaluation of Newborn Screening with Succinylacetone
Cystic Fibrosis Cases Missed by Newborn Bloodspot Screening—Towards a Consistent Definition and Data Acquisition
Diagnosing X-Linked Adrenoleukodystrophy after Implementation of Newborn Screening: A Reference Laboratory Perspective
NBSTRN Tools to Advance Newborn Screening Research and Support Newborn Screening Stakeholders
Newborn Screening with (C16 + C18:1)/C2 and C14/C3 for Carnitine Palmitoyltransferase II Deficiency throughout Japan Has Revealed C12/C0 as an Index of Higher Sensitivity and Specificity
RBD class 1 and 2 antibody epitopes elicit around 70% neutralizing capacity against SARS-CoV-2 virus following boosting with inactivated virus vaccine- 27 Oct 2023
Missed opportunities for vaccination at point of care and their impact on coverage and urban–rural coverage inequity in the Gambia - 27 Oct 2023
Modeling COVID-19 vaccine booster-elicited antibody response and impact of infection history-
Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients –
Commensal Neisseria cinerea outer membrane vesicles as a platform for the delivery of meningococcal and gonococcal antigens to the immune system - 27 Oct 2023
Adherence to recommended vaccination policies for pre- and post-solid organ transplantation patients: A national questionnaire survey in Japan- 27 Oct 2023
Breakthrough COVID-19 infections and perceived vaccine effectiveness- 27 Oct 2023
Resilience of routine childhood immunization services in two counties in Kenya in the face of the COVID-19 pandemic- 27 Oct 2023
Impact of a hypothetical COVID-19 vaccine mandate on parental likelihood to vaccinate children: Exploring school-related concerns and vaccination decision-making- 27 Oct 2023
Analyzing an immunization resource website: User browsing trends- 27 Oct 2023
Assessing parental intention to vaccinate against COVID-19, influenza, and RSV in the United States in late 2023- 27 Oct 2023
Beyond the polysaccharide and glycoconjugate vaccines for Streptococcus pneumoniae: Does protein/peptide nanovaccines hold promises? - 27 Oct 2023
The path to eradication of rubella
Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic- 27 Oct 2023
Assessing the impact of chickenpox and shingles vaccination using intermittent enhanced surveillance in Queensland, Australia- 27 Oct 2023
A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of age- 27 Oct 2023
Clinical trial registration: ClinicalTrials.gov identifier: NCT03579459. - 27 Oct 2023
Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda- 27 Oct 2023
Comparison of pneumococcal immunogenicity elicited by the PCV13 and PCV15 vaccines in adults 18 through 49 years of age- 27 Oct 2023
Individual variation in vaccine immune response can produce bimodal distributions of protection- 27 Oct 2023
Implementation of a vaccination clinic for adult solid organ transplant candidates: A single-center experience
Sequential heterologous immunization with COVID-19 vaccines induces broader neutralizing responses against SARS-CoV-2 variants in comparison with homologous boosters - 27 Oct 2023